Chemoinformaics analysis of Methyl tetradeca-2,4-dienoate
Molecular Weight | 238.371 | nRot | 10 |
Heavy Atom Molecular Weight | 212.163 | nRig | 3 |
Exact Molecular Weight | 238.193 | nRing | 0 |
Solubility: LogS | -4.782 | nHRing | 0 |
Solubility: LogP | 5.065 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 43.9906 |
nHD | 0 | BPOL | 28.6874 |
QED | 0.32 |
Synth | 2.463 |
Natural Product Likeliness | 1.47 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.132 |
Pgp-sub | 0.003 |
HIA | 0.005 |
CACO-2 | -4.578 |
MDCK | 0.0000237 |
BBB | 0.947 |
PPB | 0.960129 |
VDSS | 0.832 |
FU | 0.0363867 |
CYP1A2-inh | 0.965 |
CYP1A2-sub | 0.65 |
CYP2c19-inh | 0.723 |
CYP2c19-sub | 0.752 |
CYP2c9-inh | 0.446 |
CYP2c9-sub | 0.87 |
CYP2d6-inh | 0.132 |
CYP2d6-sub | 0.549 |
CYP3a4-inh | 0.744 |
CYP3a4-sub | 0.216 |
CL | 5.67 |
T12 | 0.706 |
hERG | 0.137 |
Ames | 0.026 |
ROA | 0.551 |
SkinSen | 0.978 |
Carcinogencity | 0.59 |
EI | 0.943 |
Respiratory | 0.96 |
NR-Aromatase | 0.254 |
Antiviral | Yes |
Prediction | 0.783719 |